
Signal Transduction in Cancer and Immunity, Volume 361
1st Edition
Secure Checkout
Personal information is secured with SSL technology.Free Shipping
Free global shippingNo minimum order.
Table of Contents
1. The RAL Signalling Network - Cancer and Beyond
Andrea Oeckinghaus
2. NF-kB and the innate immune response
Matthew Hayden
3. STAT proteins in intestinal diseases
Suneeta Krishnareddy
4. Targeting signaling pathways to treat cancer
Thomas Postler
5. The many-sided contributions of NF-κB to T-cell biology in health and disease
Yenkel Grinberg-Bleyer
6. Charting protein dephosphorylation triggered by Toll like receptor (TLR) signalling in macrophages and their role in health and disease
Aristobolo Silva
7. TAM receptor tyrosine kinases in the immune system
Glenn Matsushima
8. Implications of microgravity-induced cell signaling alterations upon cancer cell growth, invasiveness, metastatic potential, and control by host immunity
Randal K. Gregg
9. A Most Versatile Kinase: The Catalytic Subunit of PKA in T-Cell Biology
Thomas Postler
Description
Signal Transduction in Cancer and Immunity, Volume 361 in the International Review of Cell and Molecular Biology series highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics. Each chapter is written by an international board of authors.
Key Features
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in the International Review of Cell and Molecular Biology series
- Updated release includes the latest information on signal transduction in cancer and immunity
Readership
Scientists and researchers in the field
Details
- No. of pages:
- 277
- Language:
- English
- Copyright:
- © Academic Press 2021
- Published:
- 1st June 2021
- Imprint:
- Academic Press
- Hardcover ISBN:
- 9780128237571
Ratings and Reviews
About the Serial Volume Editors

Lorenzo Galluzzi
Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology. Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
Affiliations and Expertise
Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USA
Thomas Postler
Thomas Postler, PhD, is an Assistant Professor of Microbiology & Immunology at the Columbia University Medical Center where he studies transcriptional regulation in immune cells.
Affiliations and Expertise
Assistant Professor of Microbiology and Immunology, Columbia University Medical Center, USA
Request Quote
Tax Exemption
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.